Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...

A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing global efforts to end the HIV/Aids epidemic.

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

Innovator calls on researchers to examine AI symbiosis for HIV By Admire Moyo, ITWeb news editorJohannesburg, 19 Sept 2025A ...

Landmark study on HIV antibodies b12 and bNAbs, their challenges, and regional effectiveness, emphasizing global HIV research ...

Despite marked progress in the HIV response in 2024, this year has seen many disruptions to HIV prevention programmes and ...

A photo of a spiky creature has been widely shared online in Tanzania and Kenya with claims that it shows the human immunodeficiency virus (HIV) under a microscope. But this is false; the image ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

Lenacapavir, a Long-acting injectable drug used to prevent HIV, will be made available for $40 a year in over 120 low- and middle-income countries, under a new agreement announced this week between ...

Stem cells made a public splash with large research breakthroughs in the 90s and early 2000s. However, since then, stem cells ...